Showing results (151-160 of 228) with videos related to
Sort By:
Pageof 23
The Journal of Urology|September 1, 1996
Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasiaL S Marks, F J Dorey, T Rhodes, et al.Cancer|July 1, 1992
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancerA W Partin, G D Steinberg, R V Pitcock, et al.Urology|March 15, 2001
Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancerJ T Batuello, E J Gamito, E D Crawford, et al.Cancer Research|February 15, 1993
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancerA W Partin, R H Getzenberg, M J CarMichael, et al.The Journal of Rheumatology|February 1, 1984
Clinical associations of fibroblast growth promoting factor in sclerodermaS R Potter, J Bienenstock, P Lee, et al.The Journal of Urology|July 18, 2001
Clinical significance of denuded urothelium in bladder biopsyA W Levi, S R Potter, M P Schoenberg, et al.Urology|June 28, 2000
Laparoscopic ileal conduit: five-year follow-upS R Potter, T C Charambura, J B Adams, et al.Cancer|April 8, 1999
Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsT J Polascik, M J Manyak, M K Haseman, et al.Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.Urology|January 11, 2000
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomyM Han, P B Snow, J I Epstein, et al.Pageof 23